000766 通化金马
已收盘 07-22 15:00:00
资讯
新帖
简况
通化金马(000766)7月19日主力资金净卖出3430.62万元
证券之星 · 09:20
通化金马(000766)7月19日主力资金净卖出3430.62万元
通化金马:有关新药工作进展请以公司已发布的正式公告为准
证券之星 · 07-17
通化金马:有关新药工作进展请以公司已发布的正式公告为准
通化金马:公司严格按照CDE有关法律、法规及指导原则开展新药上市申请有关工作
证券之星 · 07-16
通化金马:公司严格按照CDE有关法律、法规及指导原则开展新药上市申请有关工作
通化金马:公司的重大信息均会在指定信息披露媒体发布,届时请投资者关注公司公告
证券之星 · 07-05
通化金马:公司的重大信息均会在指定信息披露媒体发布,届时请投资者关注公司公告
通化金马(000766)6月28日主力资金净卖出9984.49万元
证券之星 · 07-01
通化金马(000766)6月28日主力资金净卖出9984.49万元
通化金马:公司产品情况请参阅公司已披露的定期报告
证券之星 · 06-27
通化金马:公司产品情况请参阅公司已披露的定期报告
通化金马:公司正按照既定工作计划,正常推进新药上市申请的有关工作
证券之星 · 06-25
通化金马:公司正按照既定工作计划,正常推进新药上市申请的有关工作
民营医院概念盘中跳水,通化金马跌1.53%
自选股智能写手 · 06-24
民营医院概念盘中跳水,通化金马跌1.53%
通化金马(000766)6月21日主力资金净买入3182.01万元
证券之星 · 06-24
通化金马(000766)6月21日主力资金净买入3182.01万元
通化金马(000766)6月20日主力资金净卖出6029.89万元
证券之星 · 06-21
通化金马(000766)6月20日主力资金净卖出6029.89万元
通化金马:有关公司生产经营方面的详细信息请参阅公司已披露的定期报告
证券之星 · 06-20
通化金马:有关公司生产经营方面的详细信息请参阅公司已披露的定期报告
通化金马:我公司研制的琥珀八氢氨吖啶片主要用于治疗轻中度阿尔茨海默病
证券之星 · 06-19
通化金马:我公司研制的琥珀八氢氨吖啶片主要用于治疗轻中度阿尔茨海默病
阿尔茨海默概念盘中拉升,通化金马涨0.71%
自选股智能写手 · 06-14
阿尔茨海默概念盘中拉升,通化金马涨0.71%
通化金马:目前公司研发的是琥珀八氢氨吖啶片,是一种口服固体制剂
证券之星 · 06-13
通化金马:目前公司研发的是琥珀八氢氨吖啶片,是一种口服固体制剂
通化金马:公司密切关注行业前沿技术的发展动态,根据市场需求,结合自身情况,审慎论证
证券之星 · 06-11
通化金马:公司密切关注行业前沿技术的发展动态,根据市场需求,结合自身情况,审慎论证
6月5日通化金马现1笔大宗交易 机构净买入236.21万元
证券之星 · 06-05
6月5日通化金马现1笔大宗交易 机构净买入236.21万元
通化金马:公司全资子公司圣泰生物向银行申请贷款是为满足圣泰生物实际经营与业务发展资金需求
证券之星 · 05-31
通化金马:公司全资子公司圣泰生物向银行申请贷款是为满足圣泰生物实际经营与业务发展资金需求
通化金马:公司将努力做好经营管理,进一步提高公司竞争力,争取早日提升业绩以回馈广大投资者
证券之星 · 05-28
通化金马:公司将努力做好经营管理,进一步提高公司竞争力,争取早日提升业绩以回馈广大投资者
通化金马(000766)5月27日主力资金净卖出5429.24万元
证券之星 · 05-28
通化金马(000766)5月27日主力资金净卖出5429.24万元
通化金马:有关公司研发情况请查阅公司披露的定期报告等
证券之星 · 05-20
通化金马:有关公司研发情况请查阅公司披露的定期报告等
加载更多
公司概况
公司名称:
通化金马药业集团股份有限公司
所属行业:
医药制造业
上市日期:
1997-04-30
主营业务:
通化金马药业集团股份有限公司主要从事医药产品的研发、生产与销售。主要产品有复方嗜酸乳杆菌片、风湿祛痛胶囊、清肝健脾口服液、芩石利咽口服液。公司经历多年发展,获得行业认可,荣获“中华民族医药百强品牌企业”,2023年获得“2022-2023年度中国医药制造业百强”等称号。子公司圣泰生物先后被评为哈尔滨市“小巨人”企业、黑龙江省民营科技“巨星”企业、黑龙江省专精特新小巨人企业、国家高新技术企业、国家火炬计划重点高新技术企业等多项荣誉。
发行价格:
7.23
{"stockData":{"symbol":"000766","market":"SZ","secType":"STK","nameCN":"通化金马","latestPrice":16.01,"timestamp":1721631795000,"preClose":16,"halted":0,"volume":8647165,"delay":0,"floatShares":966000000,"shares":966000000,"eps":0.0478,"marketStatus":"已收盘","marketStatusCode":5,"change":0.01,"latestTime":"07-22 15:00:00","open":15.99,"high":16.14,"low":15.83,"amount":138000000,"amplitude":0.0194,"askPrice":16.01,"askSize":65,"bidPrice":16,"bidSize":408,"shortable":0,"etf":0,"ttmEps":0.0478,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"adjPreClose":16,"symbolType":"stock","openAndCloseTimeList":[[1721611800000,1721619000000],[1721624400000,1721631600000]],"highLimit":17.6,"lowLimit":14.4,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":966494707,"pbRate":6.65,"roa":"--","roe":"0.4%","epsLYR":0.05,"committee":-0.0552,"marketValue":15474000000,"floatMarketCap":15465000000,"peRate":334.937233,"changeRate":0.0006,"turnoverRate":0.009,"status":0},"requestUrl":"/m/hq/s/000766","defaultTab":"news","newsList":[{"id":"2453200656","title":"通化金马(000766)7月19日主力资金净卖出3430.62万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453200656","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453200656?lang=zh_cn&edition=full","pubTime":"2024-07-22 09:20","pubTimestamp":1721611218,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月19日收盘,通化金马报收于16.0元,下跌2.14%,换手率1.32%,成交量12.76万手,成交额2.06亿元。近5日资金流向一览见下表:通化金马融资融券信息显示,融资方面,当日融资买入1253.4万元,融资偿还1852.67万元,融资净偿还599.27万元。通化金马主营业务:医药产品的研发、生产与销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200002721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766","BK0060","BK0239","BK0077"],"gpt_icon":0},{"id":"2452139911","title":"通化金马:有关新药工作进展请以公司已发布的正式公告为准","url":"https://stock-news.laohu8.com/highlight/detail?id=2452139911","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452139911?lang=zh_cn&edition=full","pubTime":"2024-07-17 18:04","pubTimestamp":1721210668,"startTime":"0","endTime":"0","summary":"证券之星消息,通化金马07月17日在投资者关系平台上答复投资者关心的问题。如不存在故意拖延,贵公司生产副总的言论是否存在发布不实信息的情形?公司严格按照CDE有关法律、法规及指导原则开展新药上市申请有关工作。目前根据CDE相关要求,公司正按既定工作计划正常推进。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700037585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","000766","BK0077"],"gpt_icon":0},{"id":"2451796553","title":"通化金马:公司严格按照CDE有关法律、法规及指导原则开展新药上市申请有关工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2451796553","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451796553?lang=zh_cn&edition=full","pubTime":"2024-07-16 17:04","pubTimestamp":1721120656,"startTime":"0","endTime":"0","summary":"证券之星消息,通化金马07月16日在投资者关系平台上答复投资者关心的问题。投资者:公司原计划于5月后提交新药注册申请,7、8月份配合CDE对现场研发中心和现场生产中心进行核查。目前根据CDE相关要求,公司正按既定工作计划正常推进。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600035152.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0077","000766"],"gpt_icon":0},{"id":"2449259399","title":"通化金马:公司的重大信息均会在指定信息披露媒体发布,届时请投资者关注公司公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2449259399","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449259399?lang=zh_cn&edition=full","pubTime":"2024-07-05 17:04","pubTimestamp":1720170280,"startTime":"0","endTime":"0","summary":"投资者:目前中国AD诊断赛道参与厂商数量较少,公司提前布局通化金马董秘:您好,您的建议公司将认真研究和对待,感谢关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070500033696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","000766","BK0239","BK0077"],"gpt_icon":0},{"id":"2448938106","title":"通化金马(000766)6月28日主力资金净卖出9984.49万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448938106","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448938106?lang=zh_cn&edition=full","pubTime":"2024-07-01 09:02","pubTimestamp":1719795771,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年6月28日收盘,通化金马报收于16.19元,下跌3.57%,换手率2.66%,成交量25.7万手,成交额4.2亿元。6月28日的资金流向数据方面,主力资金净流出9984.49万元,占总成交额23.75%,游资资金净流入4758.58万元,占总成交额11.32%,散户资金净流入5225.91万元,占总成交额12.43%。近5日资金流向一览见下表:通化金马融资融券信息显示,融资方面,当日融资买入2364.25万元,融资偿还7667.15万元,融资净偿还5302.9万元。通化金马主营业务:医药产品的研发、生产与销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070100003015.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000766","BK0077","BK0060"],"gpt_icon":0},{"id":"2446358519","title":"通化金马:公司产品情况请参阅公司已披露的定期报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2446358519","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446358519?lang=zh_cn&edition=full","pubTime":"2024-06-27 17:03","pubTimestamp":1719479030,"startTime":"0","endTime":"0","summary":"证券之星消息,通化金马(000766)06月27日在投资者关系平台上答复投资者关心的问题。投资者:公司生产维生素D3吗?通化金马董秘:您好,公司产品情况请参阅公司已披露的定期报告。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062700033022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766","BK0239","BK0060","BK0077"],"gpt_icon":0},{"id":"2446818227","title":"通化金马:公司正按照既定工作计划,正常推进新药上市申请的有关工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2446818227","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446818227?lang=zh_cn&edition=full","pubTime":"2024-06-25 18:04","pubTimestamp":1719309888,"startTime":"0","endTime":"0","summary":"证券之星消息,通化金马06月25日在投资者关系平台上答复投资者关心的问题。投资者:已经到达CDE相关规定260天,为何还没提交?本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062500034826.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766","BK0060","BK0239","BK0077"],"gpt_icon":0},{"id":"2445509220","title":"民营医院概念盘中跳水,通化金马跌1.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445509220","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445509220?lang=zh_cn&edition=full","pubTime":"2024-06-24 10:20","pubTimestamp":1719195622,"startTime":"0","endTime":"0","summary":"06月24日,民营医院概念盘中跳水,截至10点20分,民营医院概念整体指数下跌3.06%,报1297.620点。从个股上来看,该概念的成分股中,通化金马跌1.53%,安科生物、ST康美、新华医疗跌幅居前。从资金上来看,截止发稿,民营医院概念主力净流入为-1.64亿,其中新华医疗受到资金热捧,主力净流入914.53万;拉长时间线来看,该板块近20日主力资金净流入-47.60亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624102022af8ecbe5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624102022af8ecbe5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0077","BK0060","600587","BK0028","BK0188","BK0239","BK0251","000766"],"gpt_icon":0},{"id":"2445932160","title":"通化金马(000766)6月21日主力资金净买入3182.01万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445932160","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445932160?lang=zh_cn&edition=full","pubTime":"2024-06-24 09:12","pubTimestamp":1719191536,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年6月21日收盘,通化金马报收于17.67元,上涨4.56%,换手率2.1%,成交量20.29万手,成交额3.51亿元。近5日资金流向一览见下表:通化金马融资融券信息显示,融资方面,当日融资买入7074.5万元,融资偿还2110.36万元,融资净买入4964.14万元,净买入额两市排名第5。通化金马主营业务:医药产品的研发、生产与销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062400001815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0060","000766"],"gpt_icon":0},{"id":"2445272850","title":"通化金马(000766)6月20日主力资金净卖出6029.89万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445272850","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445272850?lang=zh_cn&edition=full","pubTime":"2024-06-21 09:22","pubTimestamp":1718932947,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年6月20日收盘,通化金马报收于16.9元,下跌4.9%,换手率2.63%,成交量25.43万手,成交额4.37亿元。6月20日的资金流向数据方面,主力资金净流出6029.89万元,占总成交额13.81%,游资资金净流入3031.99万元,占总成交额6.94%,散户资金净流入2997.89万元,占总成交额6.86%。近5日资金流向一览见下表:通化金马融资融券信息显示,融资方面,当日融资买入4613.09万元,融资偿还3950.25万元,融资净买入662.85万元。通化金马主营业务:医药产品的研发、生产与销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062100015735.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766","BK0239","BK0060","BK0077"],"gpt_icon":0},{"id":"2444829613","title":"通化金马:有关公司生产经营方面的详细信息请参阅公司已披露的定期报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2444829613","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444829613?lang=zh_cn&edition=full","pubTime":"2024-06-20 18:04","pubTimestamp":1718877850,"startTime":"0","endTime":"0","summary":"证券之星消息,通化金马(000766)06月20日在投资者关系平台上答复投资者关心的问题。投资者:解酒药进行如何?通化金马董秘:您好,有关公司生产经营方面的详细信息请参阅公司已披露的定期报告。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062000034638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","000766","BK0077"],"gpt_icon":0},{"id":"2444423051","title":"通化金马:我公司研制的琥珀八氢氨吖啶片主要用于治疗轻中度阿尔茨海默病","url":"https://stock-news.laohu8.com/highlight/detail?id=2444423051","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444423051?lang=zh_cn&edition=full","pubTime":"2024-06-19 17:03","pubTimestamp":1718787791,"startTime":"0","endTime":"0","summary":"证券之星消息,通化金马06月19日在投资者关系平台上答复投资者关心的问题。我公司研制的琥珀八氢氨吖啶片主要用于治疗轻中度阿尔茨海默病。有关公司研发方面的重要信息,请关注公司公告。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061900035121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","000766","BK0239","BK0077"],"gpt_icon":0},{"id":"2443766256","title":"阿尔茨海默概念盘中拉升,通化金马涨0.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443766256","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443766256?lang=zh_cn&edition=full","pubTime":"2024-06-14 09:39","pubTimestamp":1718329176,"startTime":"0","endTime":"0","summary":"06月14日,阿尔茨海默概念盘中拉升,截至09点39分,阿尔茨海默概念整体指数上涨0.54%,报1157.940点。从个股上来看,该概念的成分股中,通化金马涨0.71%,广誉远、万邦德、上海莱士涨幅居前。从资金上来看,截止发稿,阿尔茨海默概念概念主力净流入为-267.23万,其中广誉远受到资金热捧,主力净流入176.94万;拉长时间线来看,该板块近20日主力资金净流入-19.42亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614093937968141dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614093937968141dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","000766","BK0239","BK0060","600771","BK0077"],"gpt_icon":0},{"id":"2443093508","title":"通化金马:目前公司研发的是琥珀八氢氨吖啶片,是一种口服固体制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2443093508","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443093508?lang=zh_cn&edition=full","pubTime":"2024-06-13 18:04","pubTimestamp":1718273075,"startTime":"0","endTime":"0","summary":"证券之星消息,通化金马(000766)06月13日在投资者关系平台上答复投资者关心的问题。投资者:公司研发琥珀八氢氨注射剂吗?通化金马董秘:您好,目前公司研发的是琥珀八氢氨吖啶片,是一种口服固体制剂。投资者:湖北蕲艾集团的熏蒸液是你们工厂生产的吗通化金马董秘:您好,目前公司无此产品。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061300034306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","000766","BK0060"],"gpt_icon":0},{"id":"2442035238","title":"通化金马:公司密切关注行业前沿技术的发展动态,根据市场需求,结合自身情况,审慎论证","url":"https://stock-news.laohu8.com/highlight/detail?id=2442035238","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442035238?lang=zh_cn&edition=full","pubTime":"2024-06-11 17:05","pubTimestamp":1718096746,"startTime":"0","endTime":"0","summary":"证券之星消息,通化金马(000766)06月11日在投资者关系平台上答复投资者关心的问题。投资者:公司在未来开发新药过程中会计划加入AI来提高效率吗通化金马董秘:您好,公司密切关注行业前沿技术的发展动态,根据市场需求,结合自身情况,审慎论证。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061100021703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0060","000766"],"gpt_icon":0},{"id":"2441242118","title":"6月5日通化金马现1笔大宗交易 机构净买入236.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441242118","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441242118?lang=zh_cn&edition=full","pubTime":"2024-06-05 16:43","pubTimestamp":1717577016,"startTime":"0","endTime":"0","summary":"证券之星消息,6月5日通化金马发生大宗交易,交易数据如下:大宗交易成交价格16.52元,成交14.3万股,成交金额236.21万元,买方营业部为机构专用,卖方营业部为中国中金财富证券有限公司福州五四路证券营业部。近三个月该股共发生3笔大宗交易,合计成交4120.0手。该股近期无解禁股上市。截至2024年6月5日收盘,通化金马报收于16.52元,下跌0.3%,换手率1.29%,成交量12.44万手,成交额2.06亿元。该股最近90天内无机构评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060500032820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","BK0077","000766"],"gpt_icon":0},{"id":"2439950604","title":"通化金马:公司全资子公司圣泰生物向银行申请贷款是为满足圣泰生物实际经营与业务发展资金需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2439950604","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439950604?lang=zh_cn&edition=full","pubTime":"2024-05-31 17:04","pubTimestamp":1717146285,"startTime":"0","endTime":"0","summary":"证券之星消息,通化金马(000766)05月31日在投资者关系平台上答复投资者关心的问题。投资者:圣泰公司为何贷款15亿,收购公司才20几亿,每年贷款产生多少利息,如何偿还。通化金马董秘:您好,公司全资子公司圣泰生物向银行申请贷款是为满足圣泰生物实际经营与业务发展资金需求。相关信息请查阅公司在巨潮资讯网披露的公告。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024053100032851.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","000766","BK0077","161121"],"gpt_icon":0},{"id":"2438069347","title":"通化金马:公司将努力做好经营管理,进一步提高公司竞争力,争取早日提升业绩以回馈广大投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2438069347","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438069347?lang=zh_cn&edition=full","pubTime":"2024-05-28 17:04","pubTimestamp":1716887045,"startTime":"0","endTime":"0","summary":"证券之星消息,通化金马05月28日在投资者关系平台上答复投资者关心的问题。通化金马董秘:您好,相关信息请查阅公司在巨潮资讯网披露的2023年年度报告。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052800031450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766","BK0077","BK0239","BK0060"],"gpt_icon":0},{"id":"2438674293","title":"通化金马(000766)5月27日主力资金净卖出5429.24万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2438674293","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438674293?lang=zh_cn&edition=full","pubTime":"2024-05-28 09:22","pubTimestamp":1716859378,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月27日收盘,通化金马报收于15.76元,下跌1.99%,换手率1.8%,成交量17.42万手,成交额2.72亿元。近5日资金流向一览见下表:通化金马融资融券信息显示,融资方面,当日融资买入1894.56万元,融资偿还2421.69万元,融资净偿还527.13万元。融券方面,融券卖出6800.0股,融券偿还4500.0股,融券余量25.04万股,融券余额394.6万元。通化金马主营业务:医药产品的研发、生产与销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052800012043.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000766","BK0077","BK0060"],"gpt_icon":0},{"id":"2436173228","title":"通化金马:有关公司研发情况请查阅公司披露的定期报告等","url":"https://stock-news.laohu8.com/highlight/detail?id=2436173228","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436173228?lang=zh_cn&edition=full","pubTime":"2024-05-20 18:04","pubTimestamp":1716199467,"startTime":"0","endTime":"0","summary":"证券之星消息,通化金马(000766)05月20日在投资者关系平台上答复投资者关心的问题。投资者:公司有研究流感类特效药吗通化金马董秘:您好。有关公司研发情况请查阅公司披露的定期报告等。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052000019623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","000766","BK0060","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1997-04-30","address":"吉林省通化市二道江区金马路999号","stockEarnings":[{"period":"1week","weight":-0.0356},{"period":"1month","weight":-0.0996},{"period":"3month","weight":-0.0488},{"period":"6month","weight":-0.093},{"period":"1year","weight":1.9907},{"period":"ytd","weight":-0.1976}],"companyName":"通化金马药业集团股份有限公司","boardCode":"AI0027","perCapita":"16247股","boardName":"医药制造业","registeredCapital":"96649万元","compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0118},{"period":"3month","weight":-0.0271},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0591},{"period":"ytd","weight":0.0025}],"survey":" 通化金马药业集团股份有限公司主要从事医药产品的研发、生产与销售。主要产品有复方嗜酸乳杆菌片、风湿祛痛胶囊、清肝健脾口服液、芩石利咽口服液。公司经历多年发展,获得行业认可,荣获“中华民族医药百强品牌企业”,2023年获得“2022-2023年度中国医药制造业百强”等称号。子公司圣泰生物先后被评为哈尔滨市“小巨人”企业、黑龙江省民营科技“巨星”企业、黑龙江省专精特新小巨人企业、国家高新技术企业、国家火炬计划重点高新技术企业等多项荣誉。","serverTime":1721639926559,"listedPrice":7.23,"stockholders":"59452人(较上一季度减少21.07%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"通化金马(000766)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供通化金马(000766)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"通化金马,000766,通化金马股票,通化金马股票老虎,通化金马股票老虎国际,通化金马行情,通化金马股票行情,通化金马股价,通化金马股市,通化金马股票价格,通化金马股票交易,通化金马股票购买,通化金马股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"通化金马(000766)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供通化金马(000766)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}